Literature DB >> 11958728

Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit.

S Garbuzova-Davis1, A E Willing, M Milliken, S Saporta, B Sowerby, D W Cahill, P R Sanberg.   

Abstract

INTRODUCTION: The aim of this study was to determine the effect of hNT neuron transplants on motor neuron function in SOD1 (G93A) mice when motor deficits were already apparent.
METHOD: The hNT neurons were implanted into L(4)-L(5) segments of the ventral horn spinal cord of mice at 15-16 weeks of age: either G93A mice, transgenic mice carrying the normal allele for human SOD1 gene (hTg), or control wild type mice (wt). Behavioral tests (rotorod, beam balance, extension reflex, footprint) were performed prior to transplantation and at weekly intervals afterwards.
RESULTS: HNT neuron transplantation in the SOD1 mice delayed disease progression for 3-4 weeks, although lifespan was not affected.
CONCLUSION: These results suggest that hNT neuron transplantation may be a promising therapeutic strategy for ALS in the later phase of the neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11958728     DOI: 10.1080/14660820152882179

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  5 in total

1.  A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice.

Authors:  Sagit Golko-Perez; Tamar Amit; Orit Bar-Am; Moussa B H Youdim; Orly Weinreb
Journal:  Neurotox Res       Date:  2016-11-08       Impact factor: 3.911

2.  Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Sagit Golko-Perez; Silvia Mandel; Tamar Amit; Lana Kupershmidt; Moussa B H Youdim; Orly Weinreb
Journal:  Neurotox Res       Date:  2015-11-18       Impact factor: 3.911

3.  Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS.

Authors:  Svitlana Garbuzova-Davis; Samuel Saporta; Edward Haller; Irina Kolomey; Steven P Bennett; Huntington Potter; Paul R Sanberg
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

4.  Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease.

Authors:  Angelo C Lepore; Britta Rauck; Christine Dejea; Andrea C Pardo; Mahendra S Rao; Jeffrey D Rothstein; Nicholas J Maragakis
Journal:  Nat Neurosci       Date:  2008-10-19       Impact factor: 24.884

5.  Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose.

Authors:  Svitlana Garbuzova-Davis; Cyndy Davis Sanberg; Nicole Kuzmin-Nichols; Alison E Willing; Carmelina Gemma; Paula C Bickford; Christina Miller; Robert Rossi; Paul R Sanberg
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.